Your Growth Stalled. Is That a Strategy Problem or a Performance Problem?

Two numbers stop moving before anyone in the building says the word "stalled." Revenue flattens for three quarters and gets explained away one quarter at a time: a soft market, a lost account, a hire who did not work out. Margin slips a point, then another, while revenue is still climbing, which is the version that hides longest because the top line is still telling a good story.

If you own or run the business, you are the first person to feel it and close to the last to get a straight answer about why.

What happens next is consistent across Ontario businesses in the $5M to $50M range. The owner picks up the phone, and who they call largely decides what problem they are told they have. Call a strategy house and the output is a strategy. Call a systems integrator and the answer is a platform. Call a recruiter and the answer is a hire. Each of those firms is competent at what it does. Each is also describing your business through the single lens it owns, and none of them is paid to tell you that the constraint sits outside their practice.

So the diagnosis gets skipped, and the remedy gets bought first. That is the sequence this article is written to interrupt.

The two diagnoses, defined tightly enough to be tested

Most conversations about this fail because the terms are used loosely. "Strategy" gets applied to anything important and "execution" to anything difficult. Here are definitions narrow enough that you can actually test which one you have.

A strategy problem

You have a strategy problem when the business would still miss its ambition after executing its current plan flawlessly.

The plan is pointed at a prize that will not fund what you want the company to become. The market shifted, or the customer segment you built for is consolidating, or the position you hold is one a larger competitor can occupy more cheaply, or you are simply competing for a pool of revenue too small to matter at the scale you have in mind.

The tell is that the business is doing the right things well and it is not producing the result. Good people, functioning processes, disciplined delivery, and a trajectory that flattens anyway.

A performance problem

You have a performance problem when the plan is broadly right and the business cannot deliver it.

The strategy is sound and the constraint sits in the operating model: who decides what, how work moves between functions, where handoffs leak time and money, whether anyone owns the outcome as opposed to their part of it. Growth gets absorbed by coordination cost, rework, manual process, and escalation.

The tell is that the business knows what to do and does not do it reliably. Ask five leaders what the top three priorities are and you get five answers, or you get the same three answers and no one can say who is accountable for each.

Note what that definition includes: this is not about individual effort. Owners hear "performance problem" and think about people who are underperforming. Occasionally that is true. More often the operating model is producing the performance it is designed to produce, and the individuals inside it are working hard against a structure that cancels their effort out.

The third one, which gets called both

There is a third diagnosis that hides inside the first two often enough to deserve its own name: the senior team does not agree.

The strategy exists. The capability exists. What is missing is alignment on decision rights, priorities, or compensation, so effort in one part of the business quietly cancels effort in another. This presents as a performance problem, because nothing lands. It gets sold to as a strategy problem, because an off-site is easier to buy than a governance conversation. It is neither. It is a governance problem, and no amount of new plan or new system fixes it, because the mechanism by which decisions get made and rewarded has not changed.

Four questions that separate them

These four questions cost nothing and they resolve most cases. Answer them honestly rather than defensibly.

1. If the current plan were executed exactly as written, would the business hit the ambition?

Yes points to performance. No points to strategy. If the honest answer is "we do not have a plan specific enough to execute exactly," that is itself the finding, and it is a governance answer before it is a strategy one.

2. Where in the business does money leave between the sale and the delivery?

If you can name the places, you have a performance problem and you already know where. If nobody can name them, and nobody in the business is tasked with knowing, you have a performance problem and a measurement gap on top of it. If margin is genuinely intact and the volume is not there, look at strategy.

3. How many decisions reached you last week that should not have?

Count them. In an owner-led business the number is usually higher than the owner expects, and the reason is rarely that managers are timid. It is that no alternative decision route exists which is trustworthy enough to use. That is a performance and governance finding, not a talent one.

4. Does your leadership team agree on what the problem is?

If they do, the diagnosis is probably close to right and you can move to sequencing. If they do not, stop. Disagreement at that level is the finding, and buying a remedy before resolving it means the remedy will be resisted by whoever thinks the diagnosis was wrong.

What four published engagement briefs actually showed

The reason to distrust the presenting complaint is that it is usually a symptom description written by someone standing inside the problem. Four published engagement briefs make the point concretely. Each figure below comes from the linked brief.

The one where it really was strategy

A Canadian fertility clinic network had grown by acquisition to four locations, $5.7M in revenue, 45 employees and 46,000 patient files, and was running founder-led with no formal strategy. The CEO wanted to scale to 20 locations and raise growth capital, and could not articulate a coherent strategy to investors, the leadership team, or employees.

That presented as a strategy problem and it largely was one. But the diagnosis had a second half: there was no framework connecting growth, utilisation, service expansion and digitisation, and no governance capable of executing one. Both halves got built — a five-pillar strategy, and a 30-plus initiative portfolio with ownership, effort, budget and status tracking behind it. Then COVID-19 arrived three months into the mandate.

Over 14 months: revenue up 38% year over year, 30-plus strategic initiatives launched, two new clinic locations, and telemedicine live in under four weeks.

The CEO's summary is the useful part: "We had the ambition but not the structure. The engagement gave us a strategy our entire team could rally behind, the governance to execute it, and the resilience to grow through COVID."

A strategy nobody can execute is not a strategy. It is a document.

The one where the owner had already bought the wrong remedy twice

A family-owned Ontario manufacturer at $200M in revenue, 600-plus employees and three plants had margins erode three percentage points over five years while revenue grew. Each plant ran its own ERP instance, scheduling system and quality process. There was no single source of truth for inventory and customer service teams spent 40% of their time tracking orders across disconnected systems.

This is the case that should worry any owner reading this, because the misdiagnosis had already been paid for twice. In the CEO's words: "We'd tried digital transformation twice before and failed both times because we treated it as an IT project."

Two technology purchases against what was, underneath, an operating-model constraint. The third attempt was sequenced differently: a three-week diagnostic across all three plants mapping 47 processes end to end and identifying 12 critical failure points, then executive alignment with the CEO, CFO and plant managers on measurable outcomes before any vendor conversation, then a roadmap prioritised by return.

Over 12 months: $4.2M in annual cost savings, order-to-ship time cut 35%, system uptime at 99.7%, customer service productivity up 40%.

The technology in the third attempt was not dramatically better than the technology in the first two. The sequence was.

The one where the constraint was compensation and decision rights

Two Canadian professional services firms merged into a $45M combined entity. Three months in, the integration had stalled: two CRMs, two billing systems, two partner compensation models, two brands. Consultants were not cross-referring. Two senior partners had already resigned over governance and compensation ambiguity.

The deal logic was sound, so this was not a strategy problem. Nor was it a capability problem: both firms were good at what they did. The constraint was that nobody had resolved decision rights or partner compensation, and every other workstream was waiting behind that unresolved question without saying so.

Over six months: $3.2M in year-one revenue synergies, 97% client retention, 47 integration milestones hit, and no additional partner attrition.

The Managing Partner named the mechanism: "Mergers in professional services fail when they stay as two firms sharing a letterhead."

The one where the sequence was the problem

A fertility clinic network with three locations had raised growth capital and committed to six clinics in 14 months. Clinical operations were genuinely excellent, with success rates above 65% and strong patient satisfaction. Operationally the three clinics ran independently with inconsistent protocols, ad-hoc financial reporting and no formal governance, and leadership could not say which clinics were profitable or why patient acquisition costs varied by location.

Nothing here reads as a strategy problem. The strategy was clear and funded. The diagnosis was about order: there was no standard to scale onto, so doubling the footprint would have doubled the inconsistency.

Over 14 months: clinic footprint from three to six, 60-plus standard operating procedures implemented, patient NPS held above 72, and governance brought to a standard institutional investors could examine.

The pattern

In one of the four, the presenting complaint matched the constraint. In three, it did not. In one, the wrong remedy had already been bought twice before the mandate started.

That ratio is drawn from four published briefs rather than from a survey, so treat it as an illustration rather than a base rate. But the direction is worth acting on: the probability that the complaint you can articulate today is the constraint that is actually binding is not high enough to spend against without testing it.

Why owners lean toward the diagnosis they would rather have

Misdiagnosis is not a competence failure. It is a predictable consequence of three things, and recognising them in yourself is most of the fix.

Strategy is a more flattering diagnosis than performance. "The market moved" locates the problem outside the building. "We cannot execute what we already decided" locates it in the operating model that you built, staffed and approved. One of those is easier to bring to a board.

Performance problems are invisible from the top of the house. They live in handoffs — between sales and delivery, between plants, between the firm you bought and the firm you are. Nobody owns a handoff, so nobody reports on it, so it does not appear in the numbers you see monthly. It appears in the numbers you see annually, as margin.

The market sells remedies, not diagnoses. A diagnostic is a small, unglamorous purchase that may conclude the buyer does not need the seller. Very few firms lead with one. That means the diagnostic is usually the owner's job, and if the owner does not do it, it does not happen.

What each diagnosis should make you buy

Once the diagnosis is settled, the purchase decision is close to mechanical. The mismatches are where the money goes.

• A strategy problem. Buy market and position work — from someone who is also accountable for turning the conclusion into a plan a team can execute. The expensive mismatch: a strategy document with no owner and no governance behind it.
• A performance problem. Buy an operating change: decision rights, accountability, process, and the systems that support them, in that order. The expensive mismatch: a platform purchase, or a strong hire dropped into an unchanged structure and expected to survive it.
• A governance and alignment problem. Buy the decision-rights and compensation conversation, facilitated by someone who can survive holding it. The expensive mismatch: an off-site, a values exercise, or a reorganisation that moves boxes without moving authority.
• Insolvency. Buy licensed insolvency practitioners and restructuring counsel. The expensive mismatch: an operating turnaround programme the business does not have the runway to finish.

Where the diagnosis lands on performance or governance, the work is an operating mandate rather than an advisory one, which is the distinction the growth and turnaround practice is organised around: someone inside the business accountable for the change landing, rather than for the recommendation being made. That page is also explicit about the mandates it declines, including the insolvency case above and the situation where nobody senior yet agrees there is a problem.

If the honest answer is that a written recommendation would be enough, buy the recommendation. It is cheaper and it is the right product.

Run the diagnostic yourself, in the next two weeks

None of this requires an outside firm. Five steps, all of which use information already inside the business.

1. Write the ambition as a number with a date. Revenue, margin, or valuation, in a stated year. Vague ambition makes question one untestable, which is the most common reason this diagnostic stalls before it starts.

2. Ask your four most senior people, separately, what the top three priorities are. Do it in writing so the answers cannot converge in the room. Compare. Divergence points to governance; convergence with no named owner per priority points to performance.

3. Trace one order end to end. Follow a single job from first contact to cash collected, marking each handoff, each re-entry of the same data, and each wait. This is the cheapest margin diagnostic available and it usually takes half a day.

4. Log the decisions that reached you for two weeks. Note which ones genuinely required the owner. The residual is your escalation load, and its size is a measure of how much of the operating model runs through one person.

5. Then, and only then, ask what to buy. With those four inputs in hand, you can tell a strategy house, an integrator, or an operator what problem you are hiring against, and you can tell when the answer you are being given is the one the seller already had.

The one page to take to your board

Boards do not need the narrative. They need to see that the diagnosis was tested. One page, five lines:

• The ambition, as a number and a date.
• The presenting complaint, in one sentence — what is visibly wrong.
• The tested diagnosis, with the evidence from steps two through four above and an explicit note of what was ruled out.
• The purchase that follows from it, with the mismatch you are deliberately avoiding.
• What would prove the diagnosis wrong, and when you will next check.

That last line is what separates a diagnosis from a preference. If nothing could disprove it, it was not tested. A board that receives that page can challenge the reasoning instead of debating the remedy, which is a materially better use of a board.

Where this practice sits

1205 Consulting has been in practice since 2019 and is operator-led. Ghaleb El Masri leads Business Performance scoping and remains accountable for the agreed 1205 role. Any additional delivery roles, responsibilities, timing, and quality oversight are confirmed in the written scope rather than implied in advance.

If you want the diagnostic done with you rather than by you, that is what a first conversation is for, and it is a working conversation rather than a pitch: the shape of the problem, what has already been tried, who internally agrees it is a problem, and what has to be true in twelve months. You should leave it with a view on whether the answer is an operating mandate, a single executive seat, a strategy purchase, or something that belongs with counsel or an insolvency practitioner instead.

Start there.

Related reading: Why Strategy Without Execution is Just a PowerPoint · 5 Signs Your $10M-$50M Company Has Outgrown Its Leadership Structure · The Professionalization Playbook: From Founder-Led to Systems-Driven · The Fractional COO Playbook: When Mid-Market Companies Need an Operator